Fluvoxamine Maleate NDC 62135-931

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-931Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0931Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-931-90	62135093190	90 TABLET, FILM COATED in 1 BOTTLE (62135-931-90)Marketed from Dec 18, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluvoxamine Maleate
Generic name (nonproprietary): fluvoxamine maleate
Active ingredients: Fluvoxamine maleate — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075900
Marketing start: Feb 23, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 62135-931_2c617129-3c30-3713-e063-6294a90af923SPL ID 2c617129-3c30-3713-e063-6294a90af923SPL set ID b8320308-084f-43fb-9b1d-5620a0efaf46RxCUI 903884, 903887, 903891UNII 5LGN83G74VUPC 0362135933302, 0362135931902, 0362135932602
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135093190 followed by a unit qualifier and the quantity

Package 62135-0931-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Fluvoxamine maleate tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) ( 1 ). 1.1 Obsessive-Compulsive Disorder Fluvoxamine maleate tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD), as defined in DSM-III-R or DSM-IV. The obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning. Obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional beh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075900

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075900
Product	Strength	Form · route	Labeler	Product NDC
Fluvoxamine Maleate	Fluvoxamine maleate 50 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-932
Fluvoxamine Maleate	Fluvoxamine maleate 100 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-933